Chinese patent medicines combined with hormone replacement therapy for premature ovarian failure: A Bayesian network meta-analysis

Chinese patent medicines combined with hormone replacement therapy for premature ovarian failure: A Bayesian network meta-analysis

ObjectiveThe objective of this study was to compare the efficacy differences between Chinese patent medicines combined with hormone replacement therapy (HRT) in the treatment of premature ovarian failure (POF) by the Bayesian network meta-analysis (NMA) method.MethodsRandomized controlled trials (RC...

Full description

Bibliographic Details
Main Authors: Han-Zhi Zhong, Mao-Ya Li, Xiao-Lan Yin, Cheng-Li Bin, Si-Yun Zhou, Shao-Bin Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Medicine
Subjects:
Chinese patent medicine
hormone replacement therapy (HRT)
premature ovarian failure (POF)
network meta-analysis (NMA)
validity
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1043390/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.1043390/full

Similar Items